Am Fam Physician. 1999 Dec 1;60(9):2507-2508.
to the editor: A 41-year-old nurse requested a second opinion about a bowel disorder. She related her symptoms to a previous trip to Mexico, where she acquired a self-limited diarrheal illness. She complained of recurrent diarrhea that she believed was caused by a parasite acquired while she was in Mexico.
Findings on initial physical examination were unremarkable, and stool studies were negative. Because of persistent symptoms, the patient requested a gastroenterology referral. Results of multiple tests (ova and parasites, cryptosporidium antigen, giardia antigen, colonoscopy, esophagogastroduodenoscopy, mucosal biopsies and serum chemistries) were all within normal limits.
I reassured the patient that there was no evidence of an occult parasitic infection. At the time of this presentation, the patient was well groomed and appeared in no distress. She calmly explained her dilemma. She suffered no adverse consequences in other areas of her life and was not depressed. She only wanted to find and eliminate the parasite that was tormenting her. Findings on repeat physical examination were normal, and psychotherapeutic referral was suggested. The patient became hostile, promptly left the office and was lost to follow-up.
Originally described in 1894,1 delusions of parasitosis (DOP) has been variously referred to as dermatophobia, parasitophobic neuro-dermatitis, parasitophobia or entomophobia.2 Central to the diagnosis is a fixed, false belief of a parasitic infestation. Patients are usually fully functional in all other areas.
The prevalence of DOP is not known. The condition is more common in middle-age women. No risk factors have been identified, and no predilections among socioeconomic, occupational or racial backgrounds is evident. In 12 percent of patients, the delusion of parasitic infestation is shared by a significant other—a condition known as “folie a deux.”3
Patients often seek the advice of multiple physicians to seek sympathy. They often present with a container holding the purported parasite (the “matchbox sign”4). Patients often have received multiple treatments from multiple physicians and will also use self-concocted preparations to rid themselves of the perceived infestation.
Following a thorough history and physical examination, appropriate initial laboratory studies include a complete blood count, serum electrolytes, thyroid function tests, rapid plasma reagin, urinalysis and a drug screen. An electroencephalogram, B12/folate levels or computed tomography may be appropriate based on specific patient presentation.
Successful treatment of delusional parasitosis is difficult and requires formulating a sense of trust with the patient. A multidisciplinary approach is preferred. The following steps are useful in approaching patients with DOP5:
Ensure that the diagnosis is correct.
Ask how the condition has affected the patient's quality of life.
Establish the trust of the patient.
Be alert to any area where the patient will allow you to help.
Reduce the patient's sense of isolation.
Consider use of medication to ease the patient's anxiety or psychosis.
Pimozide (Orap), a neuroleptic agent, has traditionally been the drug of choice for the treatment of DOP.6 The initial dosage is 1 mg per day. This can be increased weekly by 1-mg increments until a clinical response is achieved. Most patients respond at a dosage of 4 to 10 mg per day.3 The maximum dosage is 20 mg per day.
REFERENCESshow all references
1. Musalek M, Bach M, Passweg V, Jaeger S. The position of delusional parasitosis in psychiatric nosology and classification. Psychopatholgy. 1990;23:115–24....
2. Johnson GC, Anton RF. Delusions of parasitosis: differential diagnosis and treatment. South Med J. 1985;78:914–8.
3. Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. General discussion and case illustrations. Dermatol Clin. 1996;14:429–38.
4. Gould WM, Gragg TM. Delusions of parasitosis: an approach to the problem. Arch Dermatol. 1976;112:1745–8.
5. Winsten M. Delusional parasitosis: a practical guide for the family practitioner in evaluation and treatment strategies. J Am Osteopath Assoc. 1997;97:95–9.
6. Safer DL, Wenegrat B, Roth WT. Resperidone in the treatment of delusional parasitosis: a case report. J Clin Psychopharmacol. 1997;17:131–2.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 1999 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions